295 related articles for article (PubMed ID: 25304370)
1. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
Clark NC; Friel AM; Pru CA; Zhang L; Shioda T; Rueda BR; Peluso JJ; Pru JK
Cancer Biol Ther; 2016; 17(3):262-71. PubMed ID: 26785864
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice.
Peluso JJ; Gawkowska A; Liu X; Shioda T; Pru JK
Endocrinology; 2009 Nov; 150(11):4846-54. PubMed ID: 19797399
[TBL] [Abstract][Full Text] [Related]
4. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion.
Peluso JJ; Liu X; Gawkowska A; Johnston-MacAnanny E
J Clin Endocrinol Metab; 2009 Jul; 94(7):2644-9. PubMed ID: 19417032
[TBL] [Abstract][Full Text] [Related]
5. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
7. Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer.
Peluso JJ
Steroids; 2011 Aug; 76(9):903-9. PubMed ID: 21371489
[TBL] [Abstract][Full Text] [Related]
8. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
9. Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.
Su C; Cunningham RL; Rybalchenko N; Singh M
Endocrinology; 2012 Sep; 153(9):4389-400. PubMed ID: 22778217
[TBL] [Abstract][Full Text] [Related]
10. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis.
Bali N; Arimoto JM; Iwata N; Lin SW; Zhao L; Brinton RD; Morgan TE; Finch CE
Endocrinology; 2012 Feb; 153(2):759-69. PubMed ID: 22147012
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
13. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
Sueldo C; Liu X; Peluso JJ
Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone's ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells.
Peluso JJ; Yuan A; Liu X; Lodde V
Biol Reprod; 2013 Jan; 88(1):20. PubMed ID: 23242527
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells.
Peluso JJ; Griffin D; Liu X; Horne M
Biol Reprod; 2014 Nov; 91(5):104. PubMed ID: 25253729
[TBL] [Abstract][Full Text] [Related]
16. A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis.
Lodde V; Peluso JJ
Biol Reprod; 2011 Apr; 84(4):715-22. PubMed ID: 21148105
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations.
Peluso JJ; Romak J; Liu X
Endocrinology; 2008 Feb; 149(2):534-43. PubMed ID: 17991724
[TBL] [Abstract][Full Text] [Related]
18. Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component 1 Expression in Fetal Membrane Cells.
Meng Y; Murtha AP; Feng L
Reprod Sci; 2016 Sep; 23(9):1168-78. PubMed ID: 26919974
[TBL] [Abstract][Full Text] [Related]
19. Progesterone increases blood glucose via hepatic progesterone receptor membrane component 1 under limited or impaired action of insulin.
Lee SR; Choi WY; Heo JH; Huh J; Kim G; Lee KP; Kwun HJ; Shin HJ; Baek IJ; Hong EJ
Sci Rep; 2020 Oct; 10(1):16316. PubMed ID: 33005004
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
